Sandbox Reserved 431

From Proteopedia

Revision as of 20:18, 9 March 2012 by Lynmarie K Thompson (Talk | contribs)
Jump to: navigation, search


This Sandbox is Reserved from January 19, 2016, through August 31, 2016 for use for Proteopedia Team Projects by the class Chemistry 423 Biochemistry for Chemists taught by Lynmarie K Thompson at University of Massachusetts Amherst, USA. This reservation includes Sandbox Reserved 425 through Sandbox Reserved 439.


Contents

Phosphatase Inhibitor complexes: pdb 1nny

Insert caption here

Drag the structure with the mouse to rotate

Introduction

→ Function: enzyme that decreases the amount of insulin receptor in the cell, which increases the effectiveness of the insulin produced in the body

→ Why important to diabetes: type 2 diabetes is caused by the inability to use insulin effectively. Since phosphatase inhibitors increase the effectiveness of insulin in the cell, it has proved effective in treating type 2 diabetes

→ Nonselective competitive inhibitor

→ Multiple ligand binding sites – inhibitor binds with catalytic site in “open” position. Proves competitive inhibition

→ Formed by being genetically manipulated

Overall Structure


Protein-tyrosine phosphatase - composed of 6 monomers
Each monomer is composed of 283 amino acids

This is NOT the biological unit. Talk to me if you need help with this. Prof T



The monomer has 2 β strands and 10 β sheets - some mixed and some antiparallel and 9 α helices

Binding Interactions

-This is a competitive inhibitor

-It has good selectivity over other phosphatases

-Ligand binds via 2 binding sites

-Binding is reversible


<

Additional Features

The two Arg residues depicted, Arg24 and Arg254, may participate in a salt bridge or a hydrogen bonding interaction with napthoic acid, thus providing a site 2 ligand.

Credits

Introduction - Jill Carlson

Overall Structure - Polina Berdnikova

Drug Binding Site - Brett Clinton

Additional Features - James Hamblin

References

Personal tools